About Sphere Fluidics
Sphere Fluidics is a company based in Cambridge (United Kingdom) founded in 2010. Sphere Fluidics has raised $56.67 million across 11 funding rounds from investors including Horizon Discovery, Lonza and UCB. Sphere Fluidics offers products and services including Cyto-Mine® Chroma, Cyto-Cellect® Assay Kits, and Consumables and Reagents. Sphere Fluidics operates in a competitive market with competitors including 10X Genomics, Mission Bio, Cellares, LUMICKS and Xcell Biosciences, among others.
- Headquarter Cambridge, United Kingdom
- SectorsHealthcare
- Website spherefluidics.com
- Social LinkedIn X YouTube
- Legal Name Sphere Fluidics Limited
- Date of Incorporation 24 Feb, 2010
- Jurisdiction CAMBRIDGE, ENGLAND
- Total Equity Funding$56.67M (USD)
in 11 rounds
- Latest Funding Round$40M (USD), Series C
Oct 2021
- InvestorsHorizon Discovery
& 15 more
Products & Services of Sphere Fluidics
Sphere Fluidics offers a comprehensive portfolio of products and services, including Cyto-Mine® Chroma, Cyto-Cellect® Assay Kits, and Consumables and Reagents.
High-throughput platform for single-cell analysis and isolation.
Kits for screening antibodies and cell viability.
Products for picodroplet microfluidics in cell research.
Apps and channels of Sphere Fluidics
its YouTube channel SphereBio has 80 subscribers and 17 videos.
Videos from Sphere Fluidics
The most watched videos on Sphere Fluidics's YouTube channel, SphereBio (80 subscribers). Click a video to play it here.
More on SphereBio.
Funding Insights of Sphere Fluidics
Sphere Fluidics has successfully raised a total of $56.67M across 11 strategic funding rounds. The most recent funding activity was a Series C round of $40 million completed in October 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $56.67M
- Total Rounds 11
- Last Round Series C — $40M
- Investors Count 16
Latest 10 of 11 funding rounds of Sphere Fluidics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2021 | $40M | Series C | – | Sofinnova Partners, Redmile Group | – |
| Jun 2019 | $2.9M | Series B | – | Greenwood Way Capital | |
| Jan 2019 | $2M | Series B | – | 24 Haymarket, Greenwood Way Capital | – |
| Nov 2017 | – | Grant | – | – | |
| Feb 2017 | – | Series B | – | – | |
| Feb 2016 | $7M | Series B | – | – | |
| Mar 2015 | $2.37M | Grant | – | – | |
| Jun 2014 | $2.3M | Series A | – | – | – |
| Feb 2013 | $2.47M | Series A | – | – | |
| Nov 2010 | – | Seed | – | – |
16 investors in total: 16 institutional.
Investors in Sphere Fluidics
Sphere Fluidics has secured backing from 16 investors, including venture fund and institutional investors. Prominent investors backing the company include Horizon Discovery, Lonza and UCB.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sofinnova Partners is focused on life sciences and healthcare investments. | – | sofinnovapartners.com | Paris, France | |
Early stage tech companies are introduced to suitable investors. | – | gwcinvestor.com | - | |
Tech focused VC firm investing in the UK | – | 24haymarket.com | London, United Kingdom | |
Early-stage micro-VC investments are focused on UK companies. | 1983 | oxfordtechnology.com | - | |
Tech companies are invested in by Parkwalk venture capital firm. | – | parkwalkadvisors.com | London, United Kingdom | |
Operates as an employee-owned hedge fund focused on long/short equity strategies. | 2007 | redmilegroup.com | San Francisco, United States | |
- | – | eurostars-eureka.eu | - | |
Delivers comprehensive investment services for businesses. | 1982 | lbangels.co.uk | London, United Kingdom | |
Grants and fellowships for scientific research are provided to researchers. | 1660 | royalsociety.org | London, United Kingdom | |
Provider of intellectual property management and technology consulting services | 2006 | enterprise.cam.ac.uk | Cambridge, United Kingdom |
Investor details for Sphere Fluidics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sphere Fluidics
44 people are tracked at Sphere Fluidics (13 in leadership, 5 in board & advisors, 26 in team).
| Name | Role | Group |
|---|---|---|
Jay Gerlach | Vice President Marketing | Leadership |
Denise Emsden | Vice President People And Organisational Development | Leadership |
Frank F. Craig | CEO & Director | Leadership |
Andy Earp | Director Of Finance | Leadership |
James Long | Director of Physics & Engineering at Sphere Fluidics | Leadership |
Rob Treanor | Vice President Operations | Leadership |
Richard Hammond | Chief Technical Officer | Leadership |
Philip Butterfield | Director Of Health & Safety And Facilities Management | Leadership |
Claire Cox | Global Marketing Director | Leadership |
Kian Leathers | Head Of Supply Chain | Leadership |
Xin Li | Director, Science and Technology | Leadership |
William Young | Head Of Manufacturing | Leadership |
Erroll Rueckert | Commercial Director, North America | Leadership |
Ian Gray | Director | Board & advisors |
Ian Leigh | Director | Board & advisors |
Ken Hitchner | Chairman of the Board of Directors | Board & advisors |
Tristan Vaughan | Scientific Advisor | Board & advisors |
Michael Sahm | Director | Board & advisors |
Matthew Malehorn | Regional Account Manager - Mid-atlantic And Southeast US | Team |
Hojjat Madadi | Principal Scientist-Microfluidics | Team |
24 more people are available in the full profile.
Complete people profiles for Sphere Fluidics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Sphere Fluidics
3 dated milestones of Sphere Fluidics across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Sphere Fluidics is founded.
- Funding First funding round.
- Funding Latest funding round, Series C, of $40.0M.
Competitors of Sphere Fluidics
Sphere Fluidics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Mission Bio, Cellares, LUMICKS and Xcell Biosciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 10xgenomics.com | 2012 | Pleasanton, United States | $199.9M | 961 | Instrument systems for genomic research and sequencing libraries are developed. | |
| missionbio.com | 2014 | San Francisco, United States | $110M | 109 | Single-cell multi-omics platform is provided for genotypic and phenotypic analysis. | |
| cellares.com | 2019 | San Francisco, United States | $355M | – | Medical devices for cell-based therapy manufacturing are produced. | |
| lumicks.com | 2014 | Amsterdam, Netherlands | $93.38M | – | Optical tweezers instruments for single-molecule analysis are manufactured. | |
| xcellbio.com | 2012 | San Francisco, United States | $40.9M | 11 | Cell culture analysis devices for cancer research are developed. | |
| levitasbio.com | 2017 | San Francisco, United States | $73.77M | – | Single-cell imaging platform developed via magnetic levitation technology. | |
| bionautlabs.com | 2015 | Los Angeles, United States | $63.2M | – | Miniature robots are developed for targeted drug delivery applications. | |
| atrandi.com | 2016 | Vilnius, Lithuania | $31.01M | – | Microfluidic solutions for life sciences and single-cell analysis are developed. |
Detailed competitors of Sphere Fluidics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Sphere Fluidics
Websites that share an audience with Sphere Fluidics (spherefluidics.com).
Websites whose visitors overlap most with Sphere Fluidics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| chemometec.com | 100% | 31.8K | #992,798 | View details | |
oneminuteastronomer.com | oneminuteastronomer.com | 58% | – | – | – |
pveng.com | pveng.com | 58% | – | #1,282,785 | – |
| kidsmathgamesonline.com | 58% | – | #1,645,622 | View details | |
| royalsociety.org | 58% | 408.4K | #142,166 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Sphere Fluidics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Sphere Fluidics
Complete news archive for Sphere Fluidics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Sphere Fluidics
10 companies that operate in the same segment as Sphere Fluidics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sphere Fluidics
Sphere Fluidics was founded in 2010.
Sphere Fluidics is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Sphere Fluidics is a funded company, having raised a total of $56.67M across 11 funding rounds to date.
Sphere Fluidics was founded in 2010 in Cambridge, United Kingdom, within the biotechnology sector. Single-cell analysis systems are developed using proprietary picodroplet technology. Operations focus on applications such as drug discovery and development, bioproduction and synthetic biology, cell therapy engineering, analysis and isolation, metagenomics, and single-cell disease research and diagnostics. The companys domain is spherefluidics.com.
Sphere Fluidics's top competitors include 10X Genomics, Mission Bio and Cellares.
Sphere Fluidics offers Cyto-Mine® Chroma, Cyto-Cellect® Assay Kits, and Consumables and Reagents.
Sphere Fluidics has 16 investors. Key investors include Horizon Discovery, Lonza, UCB, Cambridge Enterprise, and Oxford Technology.
Sphere Fluidics operates through Sphere Fluidics Limited.